Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Yamamichi G, Kato T, Watabe T, Hatano K, et al. Anticancer Res 2024;44:879-888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yamamichi G, Kato T, Watabe T, Hatano K, et al. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Anticancer Res 2024;44:879-888.
PMID: 38423627